GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Akorn, Inc. (AKRX) [hlAlert]

Rating:
Outperform
AKRX
up 215.06 %

Akorn, Inc. (AKRX) rated Outperform by Leerink Swann

Posted on: Thursday,  Sep 27, 2012  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Akorn, Inc. (NASDAQ: AKRX) on 09/27/2012, when the stock price was $13.08. Since
then, Akorn, Inc. has gained 215.06% as of 01/22/2016's recent price of $41.21.
If you would have followed this Leerink Swann 's recommendation on AKRX, you would have gained 215.06% of your investment in 1212 days.

Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines purchased from outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations and other pharmaceutical companies. It has a wholly owned subsidiary named Akorn (New Jersey), Inc., which operates in Somerset, New Jersey and is involved in manufacturing, product development, and administrative activities related to its ophthalmic and hospital drugs & injectables segments. The Company operates in four segments: ophthalmic, hospital drugs & injectables, biologics & vaccines and contract services.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/27/2012 8:25 AM Buy
None
13.08
as of 12/31/2012
1 Week up  0.98 %
1 Month down  -0.96 %
3 Months up  1.05 %
1 YTD up  2.14 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy